Open-label, Dose-escalation Study to Evaluate the Pharmacokinetics of Inhaled Teicoplanin in Cystic Fibrosis Patients
Clinical trial NCT04176328 · COMPLETED
Trial details
- NCT number
- NCT04176328
- Sponsor
- Neupharma Srl
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-25
- Primary completion
- 2020-09-16
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.